Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1979 1
1980 1
1982 1
1983 2
1985 1
1997 1
2000 3
2001 1
2002 1
2003 2
2004 4
2005 3
2006 4
2007 1
2008 2
2009 5
2010 7
2011 8
2012 6
2013 10
2014 14
2015 10
2016 14
2017 15
2018 12
2019 12
2020 18
2021 23
2022 17
2023 16
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for tim gastric
Search for Tim Gestrich instead (1 results)
Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K, Chen Y, Sun Y, Hu Y, Jiao L, Ma J, Yuan J, Qi C, Li Y, Gong J, Gao J, Zhang X, Li J, Zhang C, Shen L. Jia K, et al. BMC Med. 2022 Jul 11;20(1):223. doi: 10.1186/s12916-022-02421-1. BMC Med. 2022. PMID: 35811317 Free PMC article.
BACKGROUND: The FAST study identified claudin-18 (CLDN18.2) as a promising novel therapeutic target for gastric cancer (GC). However, the tumor immune microenvironment and clinicopathological features of CLDN18.2-positive GC are unclear, making it difficult to develop and …
BACKGROUND: The FAST study identified claudin-18 (CLDN18.2) as a promising novel therapeutic target for gastric cancer (GC). However, …
The effects of Tim-3 activation on T-cells in gastric cancer progression.
Yu J, Zhang H, Sun S, Sun S, Li L. Yu J, et al. Oncol Lett. 2019 Feb;17(2):1461-1466. doi: 10.3892/ol.2018.9743. Epub 2018 Nov 21. Oncol Lett. 2019. PMID: 30675200 Free PMC article.
Peripheral blood, cancerous and paracancerous tissues were collected from patients with gastric cancer. T-cell immunoglobulin mucin domain-3 (Tim-3) expression in T-cells was measured and the correlation between Tim-3 expression and the T staging of gastri …
Peripheral blood, cancerous and paracancerous tissues were collected from patients with gastric cancer. T-cell immunoglobulin mucin d …
Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
Cheng G, Li M, Wu J, Ji M, Fang C, Shi H, Zhu D, Chen L, Zhao J, Shi L, Xu B, Zheng X, Wu C, Jiang J. Cheng G, et al. Int J Clin Exp Pathol. 2015 Aug 1;8(8):9452-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26464703 Free PMC article.
The Tim-3 expression was assessed in 52 gastric cancer specimens and 15 gastritis tissues by flow cytometry, and gastritis tissues served as the control. ...These results suggest that Tim-3 played an important role in the development and progression of gas …
The Tim-3 expression was assessed in 52 gastric cancer specimens and 15 gastritis tissues by flow cytometry, and gastritis tis …
Preface.
Kieffer TJ. Kieffer TJ. J Diabetes Investig. 2016 Apr;7 Suppl 1(Suppl 1):3. doi: 10.1111/jdi.12504. J Diabetes Investig. 2016. PMID: 27383412 Free PMC article. No abstract available.
Tim-3 Up-regulation in Patients with Gastric Cancer and Peptic Ulcer Disease.
Naghavi-Alhosseini M, Tehrani M, Ajami A, Rafiei A, Taghvaei T, Vahedi-Larijani L, Hossein-Nataj H, Asgarian-Omran H. Naghavi-Alhosseini M, et al. Asian Pac J Cancer Prev. 2017 Mar 1;18(3):765-770. doi: 10.22034/APJCP.2017.18.3.765. Asian Pac J Cancer Prev. 2017. PMID: 28441784 Free PMC article.
In the present study, expression of Tim-3 was evaluated in gastric cancer (GC) and peptic ulcer disease (PUD) at both mRNA and protein levels. ...Targeted immunotherapy by blocking of inhibitory receptors like Tim-3 could be a promising approach for gastri …
In the present study, expression of Tim-3 was evaluated in gastric cancer (GC) and peptic ulcer disease (PUD) at both mRNA and …
Immunoregulation effects of TIM-3 on tumors.
Sheng CC, Han FY. Sheng CC, et al. Neoplasma. 2019 Mar 5;66(2):167-175. doi: 10.4149/neo_2018_180610N385. Epub 2018 Oct 13. Neoplasma. 2019. PMID: 30509105 Review.
Immune factors affect in vivo tumor cell survival and expansion, and cancer patients have obvious cell immune dysfunction and low anti-tumor immunity. TIM-3 can be widely expressed in a variety of immune cells and it affects both innate and adaptive immune response by regu …
Immune factors affect in vivo tumor cell survival and expansion, and cancer patients have obvious cell immune dysfunction and low anti-tumor …
Association between Tim-3 and Gal-9 expression and gastric cancer prognosis.
Wang Y, Zhao E, Zhang Z, Zhao G, Cao H. Wang Y, et al. Oncol Rep. 2018 Oct;40(4):2115-2126. doi: 10.3892/or.2018.6627. Epub 2018 Aug 6. Oncol Rep. 2018. PMID: 30106451
Several Gene Expression Omnibus gastric cancer databases and the K-M plotter website were used to analyze the association between the expression of Tim-3, Gal-9 and CD8A RNA and patient survival. The results demonstrated that Tim-3 was mainly expressed in imm …
Several Gene Expression Omnibus gastric cancer databases and the K-M plotter website were used to analyze the association between the …
Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.
Sun Y, Zhou X, Lucas E, Chen L, Zhang H, Chen H, Zhou F. Sun Y, et al. J Pathol Clin Res. 2024 Jan;10(1):e345. doi: 10.1002/cjp2.345. Epub 2023 Oct 5. J Pathol Clin Res. 2024. PMID: 37798754 Free PMC article.
Using CPS, patients with TIM-3 positive tumors showed significantly worse RFS (log-rank). ...In conclusion, our results show that (1) B7-H3 and TIM-3 are frequently expressed in GEA and their expression overlaps incompletely with PD-L1; and (2) both B7-H3 and TIM …
Using CPS, patients with TIM-3 positive tumors showed significantly worse RFS (log-rank). ...In conclusion, our results show that (1) …
The TNO Gastro-Intestinal Model (TIM).
Minekus M. Minekus M. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models [Internet]. Cham (CH): Springer; 2015. Chapter 5. In: Verhoeckx K, Cotter P, López-Expósito I, Kleiveland C, Lea T, Mackie A, Requena T, Swiatecka D, Wichers H, editors. The Impact of Food Bioactives on Health: in vitro and ex vivo models [Internet]. Cham (CH): Springer; 2015. Chapter 5. PMID: 29787065 Free Books & Documents. Review.
The TNO Gastro-Intestinal Model (TIM) is a multi-compartmental model, designed to realistically simulate conditions in the lumen of the gastro-intestinal tract. TIM is successfully used to study the gastro-intestinal behavior of a wide variety of feed, food and phar …
The TNO Gastro-Intestinal Model (TIM) is a multi-compartmental model, designed to realistically simulate conditions in the lumen of t …
Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases.
Zhao S, Wang R, Song S, Hao D, Han G, Song X, Zhang J, Pizzi MP, Shanbhag N, Futreal A, Badgwell B, Harada K, Calin G, Vykoukal J, Yu CY, Katayama H, Hanash SM, Wang L, Ajani JA. Zhao S, et al. iScience. 2023 May 19;26(6):106913. doi: 10.1016/j.isci.2023.106913. eCollection 2023 Jun 16. iScience. 2023. PMID: 37305699 Free PMC article.
Advanced gastric adenocarcinoma (GAC) often leads to peritoneal carcinomatosis (PC) and is associated with very poor outcome. ...Systematic comparison of expression levels of proteins and mRNAs revealed special expression patterns of key therapeutics target notably high mR …
Advanced gastric adenocarcinoma (GAC) often leads to peritoneal carcinomatosis (PC) and is associated with very poor outcome. ...Syst …
190 results